Health Care/Hospital
Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China
SHANGHAI and HONG KONG, Aug. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...
LifeWave Offers Needed Relief to Victims of 100-Year German Floods
SAN DIEGO, Aug. 24, 2021 /PRNewswire/ -- The deadly floods that battered Europe in July werecatastrophic and caused widespread damage. In Western Germany, in particular, two months of rain doused small towns and villages in just 24 hours. Flash floods destroyed homes, swept away roads, smashed da...
Hyperhuman launches the first turn-key fitness professional app featuring AI-driven auto-edit for quality video workouts & limitless revenue generation
BUCHAREST, Romania, Aug. 24, 2021 /PRNewswire/ -- Hyperhuman
Genscript Biotech Reports 2021 Interim Financial Results
Strong Momentum across All Business Segments, particularly in Gene & Cell Therapy CDMO Continue to accelerate R&D investment to capture Future Growth * Revenue of the Group for the six months ended June 30, 2021 was approximately US$229.6 million, representing an increase of 38.0% as compared...
Himalaya Therapeutics Announces Registration of its Office in Shanghai
SHANGHAI and SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China, of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, wh...
Excelra launches a re-envisioned version of GOSTAR, its structure-activity relationship application, with an innovative set of new features to accelerate the drug discovery cycle
HYDERABAD, India, Aug. 23, 2021 /PRNewswire/ -- Today, Excelra
WuXi Biologics Reports Strong 2021 Interim Results
* Revenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million * Gross Profit Grows by 191.7% Y-o-Y to RMB2,296.8 Million * Adjusted Net Profit Attributable to Owners of the Company Increases by 163.0% Y-o-Y toRMB1,768.7 Million * Gross and Net Profit Margins Reach 52.1% and 42.7%, Respectively ...
Study Confirms Viraleze Antiviral Nasal Spray Provides Protection Against SARS-CoV-2 in Challenge Model
MELBOURNE, Australia, Aug. 23, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma has announced the publication of new data demonstrating the capability of its Viraleze antiviral nasal spray to protect against SARS-CoV-2 in an animal challenge model of SARS-CoV-2 infection[1]. Viraleze adm...
RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn's
U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035 Opaganib's 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opaganib also undergoing two oncology Phase 2 U.S. studies a...
Vinamilk ramps up R&D efforts to win big globally
HO CHI MINH CITY, Vietnam, Aug. 23, 2021 /PRNewswire/ -- The Vietnam Dairy Products JSC (Vinamilk) is accelerating R&D efforts to create innovative products enriched with local flavours to satisfy global customers' diverse tastes. With its strategic investment in product development, internation...
Everest Medicines to Announce Half-Year 2021 Interim Results
SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...
Jebsen Group Charitable Fund Establishes Significant New Partnerships with Five Hong Kong Mental Health Charities
HONG KONG, Aug. 23, 2021 /PRNewswire/ -- Jebsen Group announced today that the Jebsen Group Charitable Fund has partnered with and made donations to five of Hong Kong's notable mental health charities - Mental Health Foundation HK, Comfort Care Concern Group, Hong Kong Expressive Arts Therapy Serv...
AXA Hong Kong and HSBC jointly launch Overseas StudySurance
HONG KONG, Aug. 23, 2021 /PRNewswire/ -- With the increasing popularity of overseas study, AXA Hong Kong ("AXA") and HSBC launch a new insurance plan "Overseas StudySurance" to provide extensive care for students getting education abroad. With annual premium as low asHKD4,000, students can enjoy ...
Codex Beauty Labs is the Official Skincare of SupermodelMe Revolution SMM
SAN JOSE, Calif., Aug. 23, 2021 /PRNewswire/ -- Codex Beauty Labs, a plant-powered biotech skincare brand, is proud to announce that they are the Official Skincare for SMM Season 6 SupermodelMe Revolution. "We are honored to be the Official Skincare for the show! Codex Beauty Labs is revolutioni...
NeuExcell Therapeutics names Russ Addis as Vice President, Research
STATE COLLEGE, Penn., Aug. 23, 2021 /PRNewswire/ -- NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Russ Addis, Ph.D. to the new position of Vice President, Research, effective immediately. Dr. Addis will report directly to Dr. Ronald HW Lorijn, Chief Executive ...
OTSAW 'UV-C LED Disinfection Ecosystem' was Launched
SINGAPORE, Aug. 23, 2021 /PRNewswire/ -- OTSAW 'UV-C LED Disinfection Ecosystem'
trilogy debuts duringSingapore's recent pandemic heightened alert. This
pragmatic approach and attitude to living in an endemic, comprises of the
AirGuard, O-RX, & TreX.
Menarini Enters into an Exclusive Licensing Agreement with Daiichi Sankyo to Commercialise TARLIGE(R) in Singapore, Malaysia, and the Philippines
SINGAPORE, Aug. 23, 2021 /PRNewswire/ -- A. Menarini Asia-Pacific Holdings Pte. Ltd., part of the leading Italian global biopharmaceutical company Menarini Group, signed a multi-year exclusive licensing agreement to assume the registration, sales, marketing, and distribution of the orally adminis...
Inclusion of Kintor as a Constituent Stock of HSCI
SUZHOU, China, Aug. 23, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company's stock has been included in the Hang Seng Composite ...
Ocumension Therapeutics Announces 2021 Interim Results
Company loss narrowed sharply by 96% Business Income Increased By More Than 26 Times Year-on-Year Core Product OT-401 Approval Imminent HONG KONG, Aug. 21, 2021 /PRNewswire/ -- The Chinese ophthalmology platform company,Ocumension Therapeutics ("Ocumension" or the "Company", together with its s...
Insilico Medicine Collaborates with BioNova to Develop Small Molecule Drugs for Hematologic Malignancies
SHANGHAI, Aug. 20, 2021 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence-driven drug discovery company, and BioNova Pharmaceuticals (Shanghai) Ltd. ("BioNova"), a clinical-stage biopharmaceutical company, today announced entry into a collaboration agreement to...
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 316 media titles]
2026-06-08 10:16DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 284 media titles]
2026-06-08 09:00